다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of stroke : JoS, v.17 no.2, 2015년, pp.210 - 215
Jung, Keun-Hwa (Department of Neurology, Seoul National University Hospital, Seoul, Korea.) , Yu, Kyung-Ho (Department of Neurology, Hallym Neurological Institute, Anyang, Korea.) , Kim, Young Dae (Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.) , Park, Jong-Moo (Department of Neurology, Eulji General Hospital, Eulji University, Seoul, Korea.) , Hong, Keun-Sik (Department of Neurology, Ilsan Paik Hospital, Inje University, Goyang, Korea.) , Rha, Joung-Ho (Department of Neurology, Inha University Hospital, Incheon, Korea.) , Kwon, Sun U. (Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.) , Bae, Hee-Joon (Department of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea.) , Heo, Ji Hoe (Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.) , Lee, Byung-Chul (Department of Neurology, Hallym Neurological Institute, Anyang, Korea.) , Yoon, Byung-Woo (Department of Neurology, Seoul National University Hospital, Seoul, Korea.)
AI-Helper
Cardioembolic stroke related to nonvalvular atrial fibrillation is associated with a high recurrence rate and high mortality and morbidity. In this population, therefore, optimal anticoagulant therapy is required to prevent the occurrence of second stroke. Oral anticoagulant, warfarin has been tradi...
1 Jung KH Lee SH Kim BJ Yu KH Hong KS Lee BC Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke) Circ Cardiovasc Qual Outcomes 2012 5 327 334 22474244
2 Kim BJ Han MK Park TH Park SS Lee KB Lee BC Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry Int J Stroke 2014 9 514 518 24256115
3 Go AS Hylek EM Phillips KA Chang Y Henault LE Selby JV Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 2001 285 2370 2375 11343485
4 Camm AJ Lip GY De Caterina R Savelieva I Atar D Hohnloser SH 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 2012 33 2719 2747 22922413
5 January CT Wann LS Alpert JS Calkins H Cleveland JC Jr Cigarroa JE 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 2014 130 e199 e267 24682347
6 Kernan WN Ovbiagele B Black HR Bravata DM Chimowitz MI Ezekowitz MD Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke 2014 45 2160 2236 24788967
7 EAFT (European Atrial Fibrillation Trial) Study Group Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European atrial fibrillation trial) study group Lancet 1993 342 1255 1262 7901582
8 Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 1994 154 1449 1457 8018000
9 Connolly SJ Ezekowitz MD Yusuf S Eikelboom J Oldgren J Parekh A Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 2009 361 1139 1151 19717844
10 Connolly SJ Wallentin L Ezekowitz MD Eikelboom J Oldgren J Reilly PA The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study Circulation 2013 128 237 243 23770747
11 Patel MR Mahaffey KW Garg J Pan G Singer DE Hacke W Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 2011 365 883 891 21830957
12 Connolly SJ Eikelboom J Joyner C Diener HC Hart R Golitsyn S Apixaban in patients with atrial fibrillation N Engl J Med 2011 364 806 817 21309657
13 Granger CB Alexander JH McMurray JJ Lopes RD Hylek EM Hanna M Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 2011 365 981 992 21870978
14 Giugliano RP Ruff CT Braunwald E Murphy SA Wiviott SD Halperin JL Edoxaban versus warfarin in patients with atrial fibrillation N Engl J Med 2013 369 2093 2104 24251359
15 Diener HC Connolly SJ Ezekowitz MD Wallentin L Reilly PA Yang S Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial Lancet Neurol 2010 9 1157 1163 21059484
16 Hankey GJ Patel MR Stevens SR Becker RC Breithardt G Carolei A Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: a subgroup analysis of ROCKET AF Lancet Neurol 2012 11 315 322 22402056
17 Diener HC Eikelboom J Connolly SJ Joyner CD Hart RG Lip GY Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial Lancet Neurol 2012 11 225 231 22305462
18 Easton JD Lopes RD Bahit MC Wojdyla DM Granger CB Wallentin L Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: a subgroup analysis of the ARISTOTLE trial Lancet Neurol 2012 11 503 511 22572202
19 Hori M Connolly SJ Zhu J Liu LS Lau CP Pais P Dabigatran versus warfarin: effects on ischemic and hemorrhagic strokes and bleeding in Asians and non-Asians with atrial fibrillation Stroke 2013 44 1891 1896 23743976
20 Ntaios G Papavasileiou V Diener HC Makaritsis K Michel P Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials Stroke 2012 43 3298 3304 23150654
21 Miller CS Grandi SM Shimony A Filion KB Eisenberg MJ Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation Am J Cardiol 2012 110 453 460 22537354
22 Dentali F Riva N Crowther M Turpie AG Lip GY Ageno W Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature Circulation 2012 126 2381 2391 23071159
23 Chatterjee S Sardar P Biondi-Zoccai G Kumbhani DJ New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation JAMA Neurol 2013 70 1486 1490 24166666
24 Ruff CT Giugliano RP Braunwald E Hoffman EB Deenadayalu N Ezekowitz MD Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 2014 383 955 962 24315724
25 Hart RG Pearce LA Aguilar MI Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med 2007 146 857 867 17577005
26 ACTIVE Investigators Connolly SJ Pogue J Hart RG Hohnloser SH Pfeffer M Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 2009 360 2066 2078 19336502
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.